Highly aspherical lenslets slow progression of myopia, finds study

Written By :  Dr. Kamal Kant Kohli
Published On 2022-11-18 14:30 GMT   |   Update On 2022-11-18 17:43 GMT
Advertisement

VIETNAM: According to research published in the American Journal of Ophthalmology, highly aspherical lenslets spectacle lenses were beneficial in reducing myopia, and the findings did not indicate a resurgence of myopia after withdrawal.

Myopia is a significant problem, estimated to afflict nearly half of the world's population by the year 2050. Any degree of myopia has been shown to increase the likelihood of problems.

Advertisement

Recent lens designs with numerous lens segments and aspherical lenslets in the mid-peripheral to peripheral section of the lens showed good efficacy in randomised clinical studies as compared to the control single vision spectacle group among spectacle lenses intended to slow myopia.

The authors conducted a short-term, prospective, double-blind, randomised, clinical trial involving cross-over of the interventions in order to determine the effectiveness of spectacle lenses with highly aspherical lenslets in slowing the progression of myopia compared to single vision spectacle lenses.

119 Vietnamese children aged 7 to 13 with spherical equivalent refractive error (SE) of -0.75 to -4.75D were randomly assigned to wear either HAL or SV, and after 6 months (Stage 1) switched to the other lens for an additional 6 months (Stage 2). After stage 2, both groups continued to wear HAL for an additional six months. Group 1 was referred as as HSH (HAL-SV-HAL) and Group 2 as SHH, based on the order in which lenses were worn at each stage (SV-HAL-HAL).

The key results included a comparison of SE and axial length (AL) between HAL and SV for each stage, as well as a comparison of SE and AL with SV between the HSH and SHH groups to see if myopia recovered after switching from HAL to SV (HSH group).

Major highlights of the study:

  • In stages 1 and 2, myopia developed more slowly with HAL than SV (SEΔ stage 1: -0.21 vs -0.27D, p=0.317; ALΔ stage 1: 0.07 vs 0.14mm, p=0.004; stage 2: 0.04 vs 0.17mm, p=0.001).
  • Between the HSH and SHH groups, there were no differences in Δ SE/AL with SV (Δ SE: -0.330.27D vs. -0.270.42D; Δ AL: 0.170.13mm vs. 0.130.15mm; p=0.092).
  • With both lenses, an average of 14 hours per day of lens usage was noted.

The researchers came to the conclusion that highly aspherical lenslets slows myopia in this cross-over trial based on comparisons between groups and within groups.

Children complied with lens wear requirements, and results when switching from HAL to SV did not indicate rebound.

REFERENCE

Sankaridurg P, Weng R, Tran H, Spiegel DP, Drobe B, Ha T, Tran YH, Naduvilath T. Spectacle lenses with highly aspherical lenslets for slowing myopia: A randomised, double-blind, cross-over clinical trial. Am J Ophthalmol. 2022 Nov 5:S0002-9394(22)00418-4. doi: 10.1016/j.ajo.2022.10.021. Epub ahead of print. PMID: 36347276.

Tags:    
Article Source : American Journal of Ophthalmology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News